Marianne Langston

Person

North Andover, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical salts of pyrimidine derivatives and method of treati...
- Patent number 12,084,431
- Issue date Sep 10, 2024
- Takeda Pharmaceutical Company Limited
- Landon J. Durak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-meth...
- Patent number 11,746,109
- Issue date Sep 5, 2023
- Takeda Pharmaceutical Company Limited
- Kentaro Iwata
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-yl...
- Patent number 11,124,519
- Issue date Sep 21, 2021
- Millennium Pharmaceuticals, Inc.
- Patricia Andres
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of E1 activating enzyme inhibitors
- Patent number 10,745,404
- Issue date Aug 18, 2020
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of a proteasome inhibitor
- Patent number 10,072,029
- Issue date Sep 11, 2018
- Millennium Pharmaceuticals, Inc.
- Marianne Langston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-...
- Patent number 10,016,427
- Issue date Jul 10, 2018
- Millennium Pharmacetuicals, Inc.
- Ian G. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfamoylating reagents
- Patent number 9,802,938
- Issue date Oct 31, 2017
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-...
- Patent number 9,187,482
- Issue date Nov 17, 2015
- Millennium Pharmaceuticals, Inc.
- Ian G. Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of E1 activating enzyme inhibitors
- Patent number 8,933,225
- Issue date Jan 13, 2015
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 3-aminothienopyridone derivatives
- Patent number 7,482,452
- Issue date Jan 27, 2009
- Celltech R&D Limited
- Graham Robert Evans
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METH...
- Publication number 20230102273
- Publication date Mar 30, 2023
- Takeda Pharmaceutical Company Limited
- Kentaro IWATA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL SALTS OF PYRIMIDINE DERIVATIVES AND METHOD OF TREATI...
- Publication number 20210309640
- Publication date Oct 7, 2021
- ARIAD Pharmaceuticals, Inc,
- Landon J. DURAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COCRYSTAL FORMS OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YL...
- Publication number 20200277294
- Publication date Sep 3, 2020
- Millennium Pharmaceuticals, Inc.
- Patricia ANDRES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
- Publication number 20180079755
- Publication date Mar 22, 2018
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CRYSTALLINE FORM OF A PROTEASOME INHIBITOR
- Publication number 20180044356
- Publication date Feb 15, 2018
- Millennium Pharmaceuticals, Inc.
- Marianne Langston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROCHLORIDE SALT OF((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL) METHYL SU...
- Publication number 20170000792
- Publication date Jan 5, 2017
- Millennium Pharmaceuticals, Inc.
- Ian G. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROCHLORIDE SALT OF((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL) METHYL SU...
- Publication number 20160030432
- Publication date Feb 4, 2016
- Millennium Pharmaceuticals, Inc.
- Ian G. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
- Publication number 20150353555
- Publication date Dec 10, 2015
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN...
- Publication number 20150133460
- Publication date May 14, 2015
- Millennium Phamaceuticals, Inc.
- Ian Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
- Publication number 20150080573
- Publication date Mar 19, 2015
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HYDROCHLORIDE SALT OF ((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL)METHYL SU...
- Publication number 20110021544
- Publication date Jan 27, 2011
- Millennium Pharmaceuticals, Inc.
- Ian G. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN...
- Publication number 20100273808
- Publication date Oct 28, 2010
- Millennium Pharmaceticals, Inc.
- Ian Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mesylate salt of an IKK inhibitor
- Publication number 20090137579
- Publication date May 28, 2009
- Millennium Pharmaceuticals, Inc.
- Frederick A. Hicks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the synthesis of E1 activating enzyme inhibitors
- Publication number 20090036678
- Publication date Feb 5, 2009
- Millennium Pharmaceuticals, Inc.
- Ian Armitage
- C07 - ORGANIC CHEMISTRY

Marianne Langston

Person

Patents Grantslast 30 patents

Pharmaceutical salts of pyrimidine derivatives and method of treati...

Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-meth...

Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-yl...

Process for the synthesis of E1 activating enzyme inhibitors

Crystalline form of a proteasome inhibitor

Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-...

Sulfamoylating reagents

Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-...

Process for the synthesis of E1 activating enzyme inhibitors

Process for preparing 3-aminothienopyridone derivatives

Patents Applicationslast 30 patents

CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METH...

PHARMACEUTICAL SALTS OF PYRIMIDINE DERIVATIVES AND METHOD OF TREATI...

COCRYSTAL FORMS OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YL...

PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS

NOVEL CRYSTALLINE FORM OF A PROTEASOME INHIBITOR

HYDROCHLORIDE SALT OF((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL) METHYL SU...

HYDROCHLORIDE SALT OF((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL) METHYL SU...

PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS

LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN...

PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS

HYDROCHLORIDE SALT OF ((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL)METHYL SU...

LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN...

Mesylate salt of an IKK inhibitor

Process for the synthesis of E1 activating enzyme inhibitors